Synaps Dx
About:
Synaps Dx focuses on the research, development and commercialization for neurodegenerative disorders including Alzheimer’s Disease.
Website: https://www.synapsdx.com
Twitter/X: getdiscern
Top Investors: Semler Scientific, Bull & Bear
Description:
Synaps Dx is a privately held company focused on the research, development, and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease.
Total Funding Amount:
$10M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Rockville, Maryland, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)synapsdx.com
Founders:
Paul Tanico
Number of Employees:
1-10
Last Funding Date:
2022-03-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai